Characterization of hepatitis B virus DNA polymerase

Area of Science:

• Virology
• Molecular Biology
• Biochemistry

Background:

• Hepatitis B virus (HBV) is a significant global health concern.
• Understanding HBV replication mechanisms is crucial for antiviral therapy and vaccine development.
• HBV core particles contain an endogenous DNA polymerase essential for viral replication.

Purpose of the Study:

• To characterize the endogenous DNA polymerase activity within HBV core particles.
• To investigate the impact of vaccine preparation treatments (heat and formalin) on polymerase activity.
• To determine the sensitivity profile of HBV DNA polymerase to various eukaryotic DNA polymerase inhibitors.

Main Methods:

• Separation of HBV particles from blood plasma containing HBe and HBs antigens (subtype adr).
• Assay of endogenous DNA polymerase activity under conditions relevant to HBV vaccine production.
• Assessment of polymerase activity following heat (60°C for 10 hr) and formalin (37°C for 90 hr) treatments.
• Evaluation of polymerase sensitivity to specific inhibitors: aphidicolin, N-ethylmaleimide, 2',3'-dideoxythymidine 5'-triphosphate, phosphonoformic acid, and 9-beta-D-arabinofuranosyladenosine 5'-triphosphate.

Main Results:

• Heat and formalin treatments significantly reduced HBV endogenous DNA polymerase activity (65% and 70% reduction, respectively).
• The HBV endogenous DNA polymerase demonstrated resistance to aphidicolin and N-ethylmaleimide.
• The polymerase was sensitive to 2',3'-dideoxythymidine 5'-triphosphate, phosphonoformic acid, and 9-beta-D-arabinofuranosyladenosine 5'-triphosphate.

Conclusions:

• HBV DNA polymerase activity is moderately affected by standard vaccine inactivation methods.
• The distinct inhibitor sensitivity profile suggests the HBV DNA polymerase is a viral-specific enzyme, not of host origin.
• These findings contribute to understanding HBV polymerase function and inform HBV vaccine design and antiviral strategies.